SFRP2 and renal pelvis/ureter urothelial carcinoma: In the current study, we validated that high stromal SFRP2 expression is considerably correlated with an aggressive clinical course and serves as an independent prognostic factor for worse survival in our well-characterized UBUC and UTUC cohorts.